Fluconazole prophylaxis for high-risk liver transplant recipients

scientific article

Fluconazole prophylaxis for high-risk liver transplant recipients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0140-6736(95)92014-5
P698PubMed publication ID7739317

P50authorBridget GunsonQ42674543
P2093author name stringM Hastings
N Fisher
D Mutimer
N Kung
P433issue8959
P407language of work or nameEnglishQ1860
P921main subjectfluconazoleQ411478
P304page(s)1234-1235
P577publication date1995-05-01
P1433published inThe LancetQ939416
P1476titleFluconazole prophylaxis for high-risk liver transplant recipients
P478volume345

Reverse relations

cites work (P2860)
Q35374928Antifungal prophylaxis during neutropenia and immunodeficiency
Q48666983Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses
Q34936576Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.
Q24550733Current and emerging azole antifungal agents
Q41753239Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care.
Q34490092Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
Q34294909Fluconazole in transplant recipients: options and limitations
Q34205622Prophylactic antifungal therapy in the intensive care unit
Q84784151Prophylaxis of invasive mycoses in solid organ transplantation
Q34509391Therapeutic dilemma of fluconazole prophylaxis in intensive care

Search more.